Yokohama City University Buys Second Cray XC50-AC Supercomputer

Yokohama City University Buys Second Cray XC50-AC Supercomputer

Cray Inc. (CRAY) was unchanged in late Wednesday trading, with shares of the supercomputer manufacturer receiving little apparent help from the company’s announcement that Yokohama City University in Japan has purchased and put a Cray XC50-AC supercomputer into production at its Advanced Medical Research Center. In addition to work on computational drug-discovery research, the university expects to use its Cray system for atomic-level molecular simulations of proteins, nucleic acids, and […]

Read More ˃
Amphastar Pharma Gains After-Hours After Getting FDA Approval for Sodium Bicarbonate Injection

Amphastar Pharma Gains After-Hours After Getting FDA Approval for Sodium Bicarbonate Injection

Amphastar Pharma (AMPH) advanced in extended trading on Wednesday after the specialty pharmaceutical company said the U.S. Food and Drug Administration has granted approval of its abbreviated new drug application (ANDA) for Sodium Bicarbonate injection 8.4% in the 50 mL Luer-Jet Prefilled Syringe System. Shares rose as much as 2.8%. For the past 40 years, the company has sold and marketed the product under the “grandfather” exception to the FDA’s […]

Read More ˃
Nikkei 225 Sheds 0.29% On Profit-Taking,

Nikkei 225 Sheds 0.29% On Profit-Taking,

The Nikkei 225 Thursday slipped back 0.29% after three days of gains, as traders booked profits after the release of soft mainland Chinese economic data, and a statement from North Korea that it would “sink” Japan and reduce the United States to “ashes and darkness” for supporting a UN Security Council resolution and sanctions over its latest nuclear test. In other news, Japan Prime Minister Shinzo Abe, in India on […]

Read More ˃
Hong Kong Hang Seng Off 0.42% On Soft China Economic Data

Hong Kong Hang Seng Off 0.42% On Soft China Economic Data

The Hong Kong Hang Seng Index fell back 0.42% Thursday, with property developers and banks extending recent retreats, after the release of weaker-than-expected mainland Chinese retail sales and industrial data. China officials reported industrial output in August increased 6.0% year-on-year, against an expected 6.6%; retail sales rose 10.1% year-on-year, against an expected 10.5%; and fixed-asset investment in urban areas rose 7.8% in the first eight months of the year over […]

Read More ˃
NovoCure Says Germany’s Federal Joint Committee Supports Clinical Trial for Optune

NovoCure Says Germany’s Federal Joint Committee Supports Clinical Trial for Optune

NovoCure (NVCR) said that the German Federal Joint Committee (Gemeinsamer Bundesausschuss or G-BA) has published a decision to support a clinical trial to study the effects of Optune on newly diagnosed glioblastoma. The proposed trial design will examine the benefit of combining Optune with radiation therapy and temozolomide prior to the initiation of maintenance temozolomide in accordance with the German Healthcare Provision Act. This decision by the G-BA is a […]

Read More ˃